Loading...

Brian Jonas, MD; PhD

Title(s)Assistant Professor, Hematology and Oncology
SchoolUniversity of California, Davis
AddressCancer Ctr So, #3016
CA 95817
Phone916-734-3772
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia. J Hematol. 2020 Sep; 9(3):79-83. Tuscano J, Poh C, Rosenberg A, Jonas B, Abedi M, Barisone G, Schwab E, Lundeberg K, Kaesberg P. PMID: 32855756.
      View in: PubMed   Mentions:
    2. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. N Engl J Med. 2020 08 13; 383(7):617-629. DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, Döhner H, Letai A, Fenaux P, Koller E, Havelange V, Leber B, Esteve J, Wang J, Pejsa V, Hájek R, Porkka K, Illés Á, Lavie D, Lemoli RM, Yamamoto K, Yoon SS, Jang JH, Yeh SP, Turgut M, Hong WJ, Zhou Y, Potluri J, Pratz KW. PMID: 32786187.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    3. A Phase I Study of Everolimus and Bendamustine in Patients With Relapsed/Refractory Lymphoid Hematologic Malignancies. Clin Lymphoma Myeloma Leuk. 2020 Jul; 20(7):453-458. Hoeg RT, Davis J, Jonas BA, Tuscano J, Rosenberg A, Abedi M. PMID: 32171691.
      View in: PubMed   Mentions:    Fields:    
    4. How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia. Leukemia. 2019 12; 33(12):2795-2804. Jonas BA, Pollyea DA. PMID: 31628431.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    5. A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia. Am J Hematol. 2019 11; 94(11):E291-E294. Tomlinson BK, Tuscano JM, Abedi M, Welborn J, Arora M, O'Donnell RT, Wun T, Jonas BA. PMID: 31379016.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsCTClinical Trials
    6. Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial. Lancet Oncol. 2019 07; 20(7):984-997. Cortes JE, Khaled S, Martinelli G, Perl AE, Ganguly S, Russell N, Krämer A, Dombret H, Hogge D, Jonas BA, Leung AY, Mehta P, Montesinos P, Radsak M, Sica S, Arunachalam M, Holmes M, Kobayashi K, Namuyinga R, Ge N, Yver A, Zhang Y, Levis MJ. PMID: 31175001.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsCTClinical Trials
    7. Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2019 08; 19(8):509-515.e1. Cortes JE, Jonas BA, Graef T, Luan Y, Stein AS. PMID: 31227358.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    8. Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science. Toxics. 2019 May 09; 7(2). Malfatti MA, Buchholz BA, Enright HA, Stewart BJ, Ognibene TJ, McCartt AD, Loots GG, Zimmermann M, Scharadin TM, Cimino GD, Jonas BA, Pan CX, Bench G, Henderson PT, Turteltaub KW. PMID: 31075884.
      View in: PubMed   Mentions:
    9. Daunorubicin-containing CLL1-targeting nanomicelles have anti-leukemia stem cell activity in acute myeloid leukemia. Nanomedicine. 2019 08; 20:102004. Lin TY, Zhu Y, Li Y, Zhang H, Ma AH, Long Q, Keck J, Lam KS, Pan CX, Jonas BA. PMID: 31055076.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    10. Optimizing survival outcomes with post-remission therapy in acute myeloid leukemia. Am J Hematol. 2019 07; 94(7):803-811. Medeiros BC, Chan SM, Daver NG, Jonas BA, Pollyea DA. PMID: 30945331.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Enasidenib in the treatment of relapsed/refractory acute myeloid leukemia: an evidence-based review of its place in therapy. Core Evid. 2019; 14:3-17. Galkin M, Jonas BA. PMID: 31118877.
      View in: PubMed   Mentions:
    12. Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma. J Natl Cancer Inst. 2019 01 01; 111(1):78-85. Rosenberg AS, Brunson A, Jonas BA, Keegan THM, Wun T. PMID: 29897481.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia. Blood. 2019 01 03; 133(1):7-17. DiNardo CD, Pratz K, Pullarkat V, Jonas BA, Arellano M, Becker PS, Frankfurt O, Konopleva M, Wei AH, Kantarjian HM, Xu T, Hong WJ, Chyla B, Potluri J, Pollyea DA, Letai A. PMID: 30361262.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    14. Complications and early mortality in patients with acute promyelocytic leukemia treated in California. Am J Hematol. 2018 11; 93(11):E370-E372. Ho G, Li Q, Brunson A, Jonas BA, Wun T, Keegan THM. PMID: 30105792.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Toward Predicting Acute Myeloid Leukemia Patient Response to 7 + 3 Induction Chemotherapy via Diagnostic Microdosing. Chem Res Toxicol. 2018 10 15; 31(10):1042-1051. Scharadin TM, Malfatti MA, Haack K, Turteltaub KW, Pan CX, Henderson PT, Jonas BA. PMID: 30152692.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    16. New and emerging therapies for acute myeloid leukaemia. J Investig Med. 2018 12; 66(8):1088-1095. Davis JR, Benjamin DJ, Jonas BA. PMID: 30127098.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Proteinuria, Hypoalbuminemia, and Chronic Lymphocytic Leukemia: An Unusual Trio. J Investig Med High Impact Case Rep. 2018 Jan-Dec; 6:2324709618764207. Wung W, Ananthakrishnan S, Jonas BA. PMID: 29568782.
      View in: PubMed   Mentions:    Fields:    
    18. Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California. Cancer. 2018 05 01; 124(9):1938-1945. Ho G, Wun T, Muffly L, Li Q, Brunson A, Rosenberg AS, Jonas BA, Keegan THM. PMID: 29451695.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study. Lancet Oncol. 2018 02; 19(2):216-228. DiNardo CD, Pratz KW, Letai A, Jonas BA, Wei AH, Thirman M, Arellano M, Frattini MG, Kantarjian H, Popovic R, Chyla B, Xu T, Dunbar M, Agarwal SK, Humerickhouse R, Mabry M, Potluri J, Konopleva M, Pollyea DA. PMID: 29339097.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCTClinical Trials
    20. Novel drug combination unleashes apoptosis in AML. Science Translational Medicine. 2018 Jan 3; 10(422):eaar7509. Brian A. Jonas. .
      View in: Publisher Site   Mentions:
    21. Vascular endothelial cells take hematopoietic stem cells to school. Science Translational Medicine. 2017 Nov 15; 9(416):eaaq1236. Brian A. Jonas. .
      View in: Publisher Site   Mentions:
    22. Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia. Case Rep Hematol. 2017; 2017:3625946. Kjelland JD, Dwyre DM, Jonas BA. PMID: 29158926.
      View in: PubMed   Mentions:
    23. Just say NO to leaky bone marrow vasculature in AML. Science Translational Medicine. 2017 Oct 4; 9(410):eaap8163. Brian A. Jonas. .
      View in: Publisher Site   Mentions:
    24. Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance. Blood Cancer J. 2017 09 08; 7(9):e605. Rosenberg AS, Brunson A, Paulus JK, Tuscano J, Wun T, Keegan THM, Jonas BA. PMID: 28885611.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. On the origin of relapse in AML. Sci Transl Med. 2017 07 12; 9(398). Jonas BA. PMID: 28701479.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    26. A new therapeutic target for myelofibrosis is cause for Gli. Sci Transl Med. 2017 05 31; 9(392). Jonas BA. PMID: 28566426.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    27. Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era. Br J Haematol. 2017 07; 178(1):72-80. Tao L, Clarke CA, Rosenberg AS, Advani RH, Jonas BA, Flowers CR, Keegan THM. PMID: 28542862.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Combination of an oncolytic virus with PD-L1 blockade keeps cancer in check. Sci Transl Med. 2017 04 19; 9(386). Jonas BA. PMID: 28424330.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    29. Early mortality and complications in hospitalized adult Californians with acute myeloid leukaemia. Br J Haematol. 2017 06; 177(5):791-799. Ho G, Jonas BA, Li Q, Brunson A, Wun T, Keegan THM. PMID: 28419422.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    30. From MDS/AML to iPSC and back again. Sci Transl Med. 2017 03 08; 9(380). Jonas BA. PMID: 28275157.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    31. KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study. Leuk Res. 2016 11; 50:123-131. Swords RT, Greenberg PL, Wei AH, Durrant S, Advani AS, Hertzberg MS, Jonas BA, Lewis ID, Rivera G, Gratzinger D, Fan AC, Felsher DW, Cortes JE, Watts JM, Yarranton GT, Walling JM, Lancet JE. PMID: 27736729.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    32. Chronic eosinophilic leukemia, NOS with t(5;12)(q31;p13)/ETV6-ACSL6 gene fusion: a novel variant of myeloid proliferative neoplasm with eosinophilia. Hum Pathol (N Y). 2016 Sep; 5:6-9. Su RJ, Jonas BA, Welborn J, Gregg JP, Chen M. PMID: 27458550.
      View in: PubMed   Mentions:
    33. Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell Activity. PLoS One. 2016; 11(7):e0159189. Jonas BA, Johnson C, Gratzinger D, Majeti R. PMID: 27428079.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    34. Individualizing Therapeutic Strategies in Acute Myeloid Leukemia: Moving Beyond the 'One-Size-Fits-All' Approach. Oncology (Williston Park). 2016 Apr; 30(4):330, 333. Jonas BA, Medeiros BC. PMID: 27085331.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    35. Translocation (6;15)(q12;q15): A Novel Mutation in a Patient with Therapy-Related Myelodysplastic Syndrome. Case Rep Hematol. 2015; 2015:318545. Ali SF, Sonu RJ, Dwyre DM, Jonas BA, Rashidi HH. PMID: 26798525.
      View in: PubMed   Mentions:
    36. Acute Myeloid Leukemia with Isolated Trisomy 19 Associated with Diffuse Myelofibrosis and Osteosclerosis. Cancers (Basel). 2015 Dec 14; 7(4):2459-65. Stelling A, Jonas BA, Rashidi HH, Abedi M, Chen M. PMID: 26694466.
      View in: PubMed   Mentions:
    37. B lymphoblastic leukemia with granules mimicking acute myeloid leukemia. Int J Hematol. 2015 Sep; 102(3):251-2. Song JY, Khojeini EV, Dwyre DM, Jonas BA. PMID: 26187696.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    38. Optimal Molecular Methods in Detecting p190 (BCR-ABL) Fusion Variants in Hematologic Malignancies: A Case Report and Review of the Literature. Case Rep Hematol. 2015; 2015:458052. Sonu RJ, Jonas BA, Dwyre DM, Gregg JP, Rashidi HH. PMID: 25949834.
      View in: PubMed   Mentions:
    39. Paraneoplastic Leukemoid Reaction as a Marker of Tumor Progression in Non-Small Cell Lung Cancer. Cancer Treat Commun. 2015; 4:15-18. McCoach CE, Rogers JG, Dwyre DM, Jonas BA. PMID: 25932381.
      View in: PubMed   Mentions:
    40. MDS prognostic scoring systems – past, present, and future. Best Pract Res Clin Haematol. 2015 Mar; 28(1):3-13. Jonas BA, Greenberg PL. PMID: 25659725.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    41. Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin. Nanomedicine (Lond). 2014; 9(12):1807-20. Zhang H, Li Y, Lin TY, Xiao K, Haddad AS, Henderson PT, Jonas BA, Chen M, Xiao W, Liu R, Lam KS, Pan CX. PMID: 24628688.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    42. Alternative mRNA splicing of corepressors generates variants that play opposing roles in adipocyte differentiation. J Biol Chem. 2011 Dec 30; 286(52):44988-99. Goodson ML, Mengeling BJ, Jonas BA, Privalsky ML. PMID: 22065574.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    43. Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogen-activated protein kinase kinase kinase cascades is determined by alternative mRNA splicing. Mol Endocrinol. 2007 Aug; 21(8):1924-39. Jonas BA, Varlakhanova N, Hayakawa F, Goodson M, Privalsky ML. PMID: 17519355.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    44. Corepressors: custom tailoring and alterations while you wait. Nucl Recept Signal. 2005; 3:e003. Goodson M, Jonas BA, Privalsky MA. PMID: 16604171.
      View in: PubMed   Mentions: 31     Fields:    
    45. Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors. J Biol Chem. 2005 Mar 04; 280(9):7493-503. Goodson ML, Jonas BA, Privalsky ML. PMID: 15632172.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansAnimalsCells
    46. SMRT and N-CoR corepressors are regulated by distinct kinase signaling pathways. J Biol Chem. 2004 Dec 24; 279(52):54676-86. Jonas BA, Privalsky ML. PMID: 15491994.
      View in: PubMed   Mentions: 40     Fields:    Translation:Cells